🔴 United Therapeutics is trading 4.1% down in after-hours trading with no confirmed catalyst

United Therapeutics is trading at $521.12 (-4.10%) in after-hours trading, with no confirmed company-specific news explaining the decline.

• On October 13, United Therapeutics announced upcoming CHEST meeting presentations, including new clinical data; the announcement does not establish a connection to the drop.
• The broader market was mixed: the Nasdaq was up 0.60% and the S&P 500 was down 0.01%, offering no clear market-wide explanation. Available information does not identify a direct catalyst for the move.